The reuse of opthalmic minims®: an unacceptable cross-infection risk?

Abstract

Aims The instillation of a combined flourescein-anaesthetic eye drop is common practice in most ophthalmology clinics. Chauvin Pharmaceuticals produce unpreserved proxymethacaine 0.5% and flourescein 0.25% in a Minims s vial (PFM) intended for single application only. Our aim was to determine whether the reuse of these eye drops for multiple applications has the potential for bacterial transmission. Methods Samples were collected from doctors in general outpatient clinics. Each sample constituted a blood agar plate inoculated with the initial drop of fluid from a PFM as a control. The vial was then used for multiple applications on consecutive patients. One of the last remaining drops was then inoculated onto an alternate marked site on the same plate to serve as the test sample. The samples were immediately transported to the Microbiology laboratory and incubated at 371C for 48 h. The results were interpreted thereafter by a Microbiologist. Results A total of 41 samples were collected by eight Samplers. In all, 7/41(17%) samples showed growth of normal conjunctiva and lid flora on the test area. These were coagulase negative Staphylococci and Corynebacterium spp. Conclusions The reuse of single application of PFM should be questioned due to the potential risk of transmitting pathogens. A change to a single use only policy would result in a projected threefold increase in the annual budget for these drops.

Multiple use of preservative-free single dose unit dexamethasone 0.1% eye drops is safe within 24 hours

“…4 16 Much higher contamination rates of 17%-45% were detected when ophthalmic SDU were used multiple times on consecutive patients in an out-patient clinic setting. 17 18 Su et al have studied microbial contamination of different preservative-free single unit-dose ocular medications, including betamethasone, in an experimental set-up (ie, without patient contact) by instilling a drop onto an agar plate five times within 24 hours. 19 They concluded there was no air contamination of the drops up to 24 hours after opening.…”

Guidelines and recommendations for the SARS-CoV-2 health emergency. Organization of ophthalmic consultations to avoid contact between healthy and asymptomatic contagious positive subjects

“…Dalle ricerche sui pazienti glaucomatosi (20) è stato evidenziato che solo il 20% dei pazienti riesce a instillare un collirio senza toccare il bulbo oculare. Il rischio di contaminazione del contenuto delle formulazioni monouso, prive di batteriostatici, è molto più elevato rispetto alle formulazioni multiuso e il riutilizzo di questi prodotti è da evitare (21,22). Ciò sottolinea l'importanza di utilizzare le formulazioni monouso per un solo paziente e di eliminare il residuo di prodotto monouso dopo la somministrazione.…”

Tear break-up time for tear film evaluation: Are moistening solutions interchangeable?

“…Indeed, pipetting 1 l of 2% fluorescein solution was found to result in an improved repeatability of TBUT measurements [7], although there remains debate regarding the increased risk of microbial contamination associated with unpreserved fluorescein solutions and the need for contact of the pipette with the ocular surface [8]. Similarly, the Dry Eye Test (DET; Amcon Laboratories, Inc., USA) was developed to deliver the same small volume of fluorescein solution by application of slightly modified impregnated strips to the superior temporal bulbar conjunctiva [1].…”